GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Other Current Liabilities

Galapagos NV (WBO:GLPG) Other Current Liabilities : €0.0 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Galapagos NV Other Current Liabilities?

Galapagos NV's other current liabilities for the quarter that ended in Sep. 2024 was €0.0 Mil.

Galapagos NV's quarterly other current liabilities stayed the same from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€0.0 Mil) but then increased from Jun. 2024 (€0.0 Mil) to Sep. 2024 (€0.0 Mil).

Galapagos NV's annual other current liabilities increased from Dec. 2021 (€0.2 Mil) to Dec. 2022 (€8.5 Mil) and increased from Dec. 2022 (€8.5 Mil) to Dec. 2023 (€32.0 Mil).

Galapagos NV Other Current Liabilities Historical Data

The historical data trend for Galapagos NV's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Other Current Liabilities Chart

Galapagos NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Galapagos NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Galapagos NV Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Galapagos NV Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (WBO:GLPG) » Definitions » Other Current Liabilities
Comparable Companies
XAMS:PHARM XAMS:VVY XAMS:BAI VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE UTHR MRNA NEUP SMMT OCSE:GMAB INCY BMRN
Traded in Other Exchanges
GLPGF:USA GLPG:USA GLPG:Netherlands GLPGa:UK 0JXZ:UK GXE:Germany GXE:Germany G1LP34:Brazil
Address
Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800
Website
https://www.glpg.com
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.